Horizon Discovery Group (LON:HZD) had its price objective cut by Peel Hunt from GBX 171 ($2.10) to GBX 108 ($1.33) in a research note released on Tuesday, Stock Target Advisor reports. They currently have a hold rating on the stock.
Shares of LON:HZD opened at GBX 97.40 ($1.20) on Tuesday. The company’s 50-day moving average is GBX 102.95 and its 200 day moving average is GBX 128.14. The company has a debt-to-equity ratio of 9.62, a quick ratio of 2.67 and a current ratio of 3.01. The company has a market capitalization of $156.88 million and a P/E ratio of -32.26. Horizon Discovery Group has a fifty-two week low of GBX 96 ($1.18) and a fifty-two week high of GBX 186.80 ($2.30).
In other Horizon Discovery Group news, insider Susan Searle purchased 10,000 shares of the company’s stock in a transaction that occurred on Monday, May 4th. The stock was bought at an average price of GBX 103 ($1.27) per share, with a total value of £10,300 ($12,675.36). Also, insider Jayesh Pankhania acquired 44,123 shares of the firm’s stock in a transaction on Friday, May 1st. The stock was purchased at an average price of GBX 102 ($1.26) per share, with a total value of £45,005.46 ($55,384.52). Over the last 90 days, insiders purchased 139,282 shares of company stock worth $14,131,605.
Horizon Discovery Group plc designs, manufactures, and applies gene editing and gene modulation to build cell models that harbour the genetics of human disease in the Americas, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company operates through Products, Services, and Leveraged Research and Development (R&D) segments.
Read More: S&P/ASX 200 Index
Receive News & Ratings for Horizon Discovery Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Horizon Discovery Group and related companies with MarketBeat.com's FREE daily email newsletter.